ComBaT Glaucoma Study for Glaucoma
This study, called ComBaT Glaucoma, is looking at whether a personalized counseling and education program can help people with glaucoma better manage their eye care. The program, called ComBaT Glaucoma, focuses on your diagnosis and why follow-up care is important for keeping your vision. Researchers want to see if providing these extra resources helps you get the eye care you need to prevent blindness. To join, you must be Black or African American, at least 40 years old, and have participated in the initial screening. The study aims to enroll 60 people and is currently unclear on its recruitment status. Success will be measured by how often participants use eye care services over 14 months.
- Study design
- This is an interventional study involving 60 participants. It is testing a behavioral intervention called ComBaT Glaucoma.
- What's involved
- Not specified in the trial record.
- Compensation
- Not stated in the trial record.
- Follow-up
- Participants will be followed for up to 14 months to measure eye care utilization.
AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.
Community Based Treatment for (ComBaT) Glaucoma
At a glance
Conditions
Where it's being run
2 sites across 1 statesStudy leadership
- Angela Elam · PRINCIPAL_INVESTIGATOR · University of Michigan
Who to contact
Opens a ready-to-send draft in your own email app — review before sending.
Do you actually qualify for this trial?
Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.
Inclusion
Exclusion
What this trial measures
- Eye care utilizationUp to 14 months
Participants who have not seen an eye care provider for an initial clinical evaluation within 6 months of entering the program or a follow-up evaluation at 12 months will be considered underutilizers. Those who have received evaluation at 6 and 12 months will be considered normal utilizers.